Clinical evidence suggests that combining both agents may produce additive benefits for weight loss and A1C reduction in patients with type 2 diabetes or metabolic syndrome
Read articleListen Press Release New Mayo Clinic Studies Demonstrate MyPhenome Test Predicts Weight Loss Outcomes Across Treatments, Including GLP-1s and Surgical Interventions PR Newswire - Menlo Park Calif
Enhances mental clarity and focus, helping reduce brain fog
Clinical Response At both Weeks 16 and 52, a greater proportion of patients treated with TALTZ 80 mg Q4W had ASAS40 response compared to patients treated with placebo (Table 10)
FIGURE 2 Clinical studies have reported controversial outcomes despite support from basic research and pre-clinical studies (Table 1)
Incorporate: Aerobic exercise, such as brisk walking, jogging or swimming, three to five times per week Resistance training, such as weightlifting and bodyweight exercises, two to three times a week Prioritize sleep